ASX:OSL OncoSil Medical (OSL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About OncoSil Medical Stock (ASX:OSL) 30 days 90 days 365 days Advanced Chart Get OncoSil Medical alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume2.17 million shsAverage VolumeN/AMarket CapitalizationA$32.25 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia. Read More Receive OSL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OncoSil Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OSL Stock News HeadlinesOncoSil Medical Appoints Dr. Thomas Duthy as New Non-Executive ChairmanSeptember 8 at 9:11 PM | tipranks.comOncoSil Medical to Present PANCOSIL Trial Results at CIRSE CongressSeptember 5, 2025 | msn.comThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.September 10 at 2:00 AM | Weiss Ratings (Ad)OncoSil Medical Full Year 2025 Earnings: AU$1.38 loss per share (vs AU$2.16 loss in FY 2024)September 1, 2025 | uk.finance.yahoo.comOncoSil Medical Appoints New Joint Company SecretariesSeptember 1, 2025 | tipranks.comOncoSil Medical Ltd Announces New Securities Quotation on ASXAugust 22, 2025 | msn.comASX:OSL Financials | Oncosil Medical Ltd - Investing.comJuly 8, 2025 | investing.comOncoSil wraps up recruitment for key pancreatic cancer trialJuly 4, 2025 | msn.comSee More Headlines OSL Stock Analysis - Frequently Asked Questions What other stocks do shareholders of OncoSil Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that OncoSil Medical investors own include Invictus Energy (IVZ), Citizens (CIA), Red Mountain Mining (RMX), National Australia Bank (NAB), Rivian Automotive (RIVN), Blackmores (BKL) and Twitter (TWTR). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:OSL CIKN/A Webwww.oncosil.com.au Phone61 2 9223 3344FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$11.91 million Net Margins-2,395.37% Pretax MarginN/A Return on Equity-280.65% Return on Assets-82.34% Debt Debt-to-Equity Ratio1.49 Current Ratio3.26 Quick Ratio6.89 Sales & Book Value Annual SalesA$1.57 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow10.91 Book ValueA$0.00 per share Price / BookN/AMiscellaneous Outstanding Shares3,780,000,000Free FloatN/AMarket CapA$32.25 million OptionableNot Optionable Beta0.91 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (ASX:OSL) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersThis stock just surpassed PalantirThe media hasn't caught up to the story yet, but when they do, this stock could leave Nvidia in the dust. I...InvestorPlace | SponsoredOne tiny company just cracked Google’s $19B problemTucked away outside San Antonio sits a facility most Americans don’t know exists. It’s not mining gold or o...True Market Insiders | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredTrump’s reported death a hoaxHow Trump’s latest policies could trigger a full-scale debt collapse… And the specific investments that cou...Porter & Company | SponsoredWorld War 3? Everything Just Changed — and One Tiny Company Is at the Center of It.Trump immediately activated a $5.3 TRILLION AI missile shield — code-named Golden Dome — to stop drone swarms ...Angel Publishing | SponsoredLitecoin’s Creator Backs the World’s First TreasuryBitcoin's corporate adoption story has been written. Litecoin's is just beginning.The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoSil Medical Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share OncoSil Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
